Opinion: Biopharma companies are spreading misinformation — and taking advantage of it
As Covid-19 upends the world, people are putting their faith in the biopharma industry to save us from this crisis. Retail investors are pouring into biopharma stocks, and when any data are released on Covid-19-related vaccines or therapies, entire markets move — even if the news from the company isn’t entirely straightforward.
Many biopharma companies (especially American ones) are benefiting from the Covid-19 pandemic.
